The Latest Data for Ruxolitinib Cream in Vitiligo: Finding Context from the Outcomes
May 10, 2023, 03:02 PM
Dermatologists Raj Chovatiya, MD, PhD, and David Rosmarin, MD, discuss new research outcomes for the topical JAK inhibitor live from the Revolutionizing Atopic Dermatitis (RAD) 2023 Annual Meeting in Washington, DC.